549
Views
6
CrossRef citations to date
0
Altmetric
Review

Treatment options after first-line immunotherapy in metastatic NSCLC

Pages 221-228 | Received 24 Nov 2019, Accepted 03 Mar 2020, Published online: 12 Mar 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Helena Bote, Andrés Mesas, Javier Baena, Mercedes Herrera & Luis Paz-Ares. (2022) Emerging immune checkpoint inhibitors for the treatment of non-small cell lung cancer. Expert Opinion on Emerging Drugs 27:3, pages 289-300.
Read now

Articles from other publishers (5)

Hazem I. Assi, Maroun Bou Zerdan, Mohammad Hodroj, Makram Khoury, Nour Sabiha Naji, Ghid Amhaz, Reine Abou Zeidane & Fadi El Karak. (2023) Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC). Oncotarget 14:1, pages 517-525.
Crossref
Xiangling Wang, Ting Wang, Yunxia Chu, Jie Liu, Cuihua Yi, Xuejun Yu, Yonggang Wang, Tianying Zheng, Fangli Cao, Linli Qu, Bo Yu, Huayong Liu, Fei Ding, Shuang Wang, Xiangbo Wang, Jing Hao & Xiuwen Wang. (2023) Could S-1-based non-platinum doublet chemotherapy be a new option as a second-line treatment for advanced non-small cell lung cancer patients? A multicenter retrospective study. Frontiers in Oncology 13.
Crossref
Walid Shalata, Muhammed Iraqi, Baisali Bhattacharya, Vered Fuchs, Laila C. Roisman, Ahron Yehonatan Cohen, Ismaell Massalha, Alexander Yakobson, Manu Prasad, Moshe Elkabets, Angel Porgador & Nir Peled. (2021) Rapid Response to the Combination of Lenvatinib and Pembrolizumab in Patients with Advanced Carcinomas (Lung Adenocarcinoma and Malignant Pleural Mesothelioma). Cancers 13:14, pages 3630.
Crossref
Arsela Prelaj, Chiara Carlotta Pircher, Giacomo Massa, Valentino Martelli, Giulia Corrao, Giuseppe Lo Russo, Claudia Proto, Roberto Ferrara, Giulia Galli, Alessandro De Toma, Carlo Genova, Barbara Alicja Jereczek-Fossa, Filippo de Braud, Marina Chiara Garassino & Sara Elena Rebuzzi. (2021) Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression. Cancers 13:6, pages 1300.
Crossref
Giacomo Pelizzari, Francesco Cortiula, Marco Giavarra, Michele Bartoletti, Camilla Lisanti, Vanessa Buoro, Monica Cattaneo, Ciro Rossetto, Simona Rizzato, Fabio Puglisi, Marianna Macerelli, Gianpiero Fasola & Alessandro Follador. (2020) Platinum-Based Chemotherapy in Older Patients with Non-Small Cell Lung Cancer: What to Expect in the Real World. Drugs & Aging 37:9, pages 677-689.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.